BIRMINGHAM, Ala., Dec. 09, 2024 (GLOBE NEWSWIRE) -- We are excited to share that Harbert Management Corporation (“HMC”) has been voted one of the Best Places to Work in Money Management for the sixth ...
ISTANBUL, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Social activist Monica Lewinsky visited Istanbul in October at the invitation of Agnivesh Agarwal, founder of Primeks Medical, a medical supplies company ...
In late 2024, new aircraft will join the Falcon Luxe fleet, including the long-range Bombardier Global Express 6500 in an ultra-premium configuration, in line with the further expansion of the fleet.
Wolters Kluwer appoints Mark Sherwood as Executive Vice President & Chief Information Officer ...
New LinkIQ Duo combines cable, Wi-Fi, and network testing in one easy-to-use solution ...
LONDON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- GFO-X announces ABN AMRO Clearing, IMC, Standard Chartered Bank and Virtu Financial as strategic partners ahead of launch in Q1 2025.
Vancouver, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB10) is pleased to highlight the polymetallic potential of its ...
The Company has resumed technical and financial studies to research the re-start of operations at its Murchison Gold Project. While the Company’s recent focus has been on optimizing production from ...
Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX) is pleased to announce that the board of directors of the Company has adopted a deferred share unit plan for the Company’s directors (the ...
The 2025 milestones reflect Evaxion’s high activity level, broad pipeline and strong external interest in potential partnerships around both our AI-Immunology™ platform and pipeline assets. As such, ...
This is Spryker’s sixth AWS competency, demonstrating its efficiency in the market, deep industry knowledge, and reliable experience in various industry ecosystems. BERLIN and N ...
AiViva Biopharma Inc., a clinical-stage biotechnology company, announced the receipt of FDA clearance for testing AIV001 (axitinib) by intradermal injection with their formulation in facial skin.